検索結果 - Henk‐Jan Guchelaar

結果の絞り込み
  1. 1
    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients

    Immunogenicity of Monoclonal Antibodies and the Potential Use of HLA Haplotypes to Predict Vulnerable Patients 著者: Romy Mosch, Henk‐Jan Guchelaar

    出版事項 2022
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms

    The efficacy and safety of eculizumab in patients and the role of C5 polymorphisms 著者: Hendrikus Bernhard Bouwman, Henk‐Jan Guchelaar

    出版事項 2024
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis

    Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis 著者: Judith A.M. Wessels, T. Huizinga, Henk‐Jan Guchelaar

    出版事項 2007
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands

    Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands 著者: Paul CD Bank, Jesse J. Swen, Henk‐Jan Guchelaar

    出版事項 2019
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

    Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines 著者: Lisanne E. N. Manson, Jesse J. Swen, Henk‐Jan Guchelaar

    出版事項 2020
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  6. 6
    Clinical development of gene- and cell-based therapies: overview of the European landscape

    Clinical development of gene- and cell-based therapies: overview of the European landscape 著者: Sofieke de Wilde, Henk‐Jan Guchelaar, Maarten L. Zandvliet, Pauline Meij

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time 著者: Emma C. Hulshof, Maarten J. Deenen, Henk‐Jan Guchelaar, Hans Gelderblom

    出版事項 2020
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  8. 8
    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review

    Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review 著者: Sylvia D. Klomp, Martijn L. Manson, Henk‐Jan Guchelaar, Jesse J. Swen

    出版事項 2020
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  9. 9
    Technologies for Pharmacogenomics: A Review

    Technologies for Pharmacogenomics: A Review 著者: Maaike van der Lee, Marjolein Kriek, Henk‐Jan Guchelaar, Jesse J. Swen

    出版事項 2020
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  10. 10
    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

    Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice 著者: Alireza Tafazoli, Henk‐Jan Guchelaar, Wojciech Miltyk, Adam Krętowski, Jesse J. Swen

    出版事項 2021
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  11. 11
    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review

    3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?—A Scoping Review 著者: Iris Lafeber, Elisabeth J. Ruijgrok, Henk‐Jan Guchelaar, Kirsten J. M. Schimmel

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review

    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review 著者: Jara M. Baas, L. L. Krens, Henk‐Jan Guchelaar, Hans Morreau, Hans Gelderblom

    出版事項 2011
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  13. 13
    Lapatinib for Advanced or Metastatic Breast Cancer

    Lapatinib for Advanced or Metastatic Breast Cancer 著者: Frans L. Opdam, Henk‐Jan Guchelaar, Jos H. Beijnen, Jan H.M. Schellens

    出版事項 2012
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  14. 14
    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)

    Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation pr... 著者: Katja S. Just, Michael Steffens, Jesse J. Swen, George P. Patrinos, Henk‐Jan Guchelaar, Julia Stingl

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    The Risk of Cancer in Users of Statins

    The Risk of Cancer in Users of Statins 著者: Matthijs R. Graaf, Annette B. Beiderbeck, Toine C. G. Egberts, Dick J. Richel, Henk‐Jan Guchelaar

    出版事項 2004
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  16. 16
    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options? 著者: Jonathan E. Knikman, Hans Gelderblom, Jos H. Beijnen, Annemieke Cats, Henk‐Jan Guchelaar, Linda M. Henricks

    出版事項 2020
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  17. 17
    Liver and kidney function in patients with Covid‐19 treated with remdesivir

    Liver and kidney function in patients with Covid‐19 treated with remdesivir 著者: Sylvia A. van Laar, Mark de Boer, Kim B. Gombert‐Handoko, Henk‐Jan Guchelaar, J. Zwaveling

    出版事項 2021
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study

    Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case–control study 著者: E.R. Koomen, Arjen Joosse, Ron M. C. Herings, M. K. Casparie, Henk‐Jan Guchelaar, Tamar Nijsten

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images

    Low literacy and written drug information: information-seeking, leaflet evaluation and preferences, and roles for images 著者: Mara M. van Beusekom, Petronella Grootens‐Wiegers, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    出版事項 2016
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review

    The extent and effects of patient involvement in pictogram design for written drug information: a short systematic review 著者: Mara M. van Beusekom, Anne H. Kerkhoven, Mark Bos, Henk‐Jan Guchelaar, Jos M. van den Broek

    出版事項 2018
    全文の入手
    Revisão
    お気に入りに追加
    保存先:

検索ツール: